Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Evodiamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108794474B reveals novel evodiamine derivatives targeting Top1/Top2/HDAC. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN120682230A reveals novel quinazolinone synthesis. Offers improved antitumor activity and scalable manufacturing for pharmaceutical intermediate supply chains.
Patent CN107629051B reveals a novel three-step carbonylation route for evodiamine, offering streamlined production and cost advantages for pharmaceutical intermediates.
Patent CN101941971B details a green synthesis of Evodiamine via catalytic hydrogenation and anhydride condensation, offering high purity and cost reduction for pharma manufacturing.
Novel bis-evodiamine derivatives with enhanced antitumor activity and scalable synthesis routes for pharmaceutical intermediates supply chain optimization.
Patent CN110092786B introduces a novel catalytic method for evodiamine synthesis enabling high-yield production through streamlined reaction sequences and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.